BridgeBio Neutral Stance From Citi Shakes ATTR-CM Outlook
Citi initiates BridgeBio at Neutral, signaling caution on ATTR-CM growth despite a strong near-term ramp. The move ad...
This guide highlights dividend ETFs with the lowest expense ratios and explains how expense structures influence long-term performance.
27,554 articlesCiti initiates BridgeBio at Neutral, signaling caution on ATTR-CM growth despite a strong near-term ramp. The move ad...
Investors watch WWDC 2026 with high expectations as Apple readies a major AI push. This preview outlines what’s at st...
GameStop posts a strong Q1 FY26 beat and authorizes a $2 billion buyback, signaling a pivot to a cash-rich model. The...
Broadcom is defying a broad market panic as AI-driven demand fuels strong cash flow and robust margins. Here's why in...
As costs rise and profits climb, a growing chorus is pushing for a $20 minimum wage. The move could reshape hiring, i...
As AMD prepares to report its second-quarter results, a bullish outlook centered on AI demand could dominate the conv...
A U.S. startup says its graphene-based, non-lithium energy storage solution is safer and faster to deploy, reporting ...
Novo Nordisk faces intense pressure in the fast-growing obesity treatment space. This article dives into whether this...
Investors are watching whether Alphabet can become the most valuable company by turning Google Cloud into a high-marg...
Walmart and Costco sit at opposite ends of the retail revenue spectrum, yet their growth stories diverge in meaningfu...
Palantir (PLTR) sits near $152 after a blowout Q1 2026. Investors weigh whether to buy, hold, or sell Palantir stock ...
AGNT, Inc. has completed its corporate transformation, changing its name and moving its domicile to Texas. The move i...